Logan Capital Management’s Medtronic MDT Stock Holding History

Logan Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$896K	Buy	+10,335	New	+$990K	0.04%	217

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Logan Capital Management's MDT Position: Q1 2026 in Review

Logan Capital Management sold out of Medtronic (MDT) in Q1 2026, closing a stake of 10,644 shares — an estimated $1.02M sold.

Logan Capital Management first reported a position in MDT in Q2 2013 and held it in 46 quarters. The position peaked at $10.9M in Q2 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Logan Capital Management reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
Logan Capital Management sold 10,644 Medtronic shares in Q1 2026, an estimated $1.02M.
Logan Capital Management first reported a position in Medtronic in Q2 2013 and held it in 46 quarters.
Logan Capital Management's Medtronic position peaked at $10.9M in Q2 2023.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.